North America and Europe Digital Therapeutic (DTx) Market Size, Share, Trends, Growth Analysis, Development, Revenue, Future Growth and Forecast to 2030
The
large scale North
America and Europe Digital Therapeutic (DTx) Market report is a synopsis
about how is the market status right now and how will it be in the forecast
years for Healthcare industry. The report gives details about the top players and
brands that are driving the market. Also, this market analysis report gives an
in-depth knowledge on what the recent developments, products launches are,
while also keeping the track for recent acquisitions, mergers, joint ventures
and competitive research in the global market industry. This marketing report
also provides the knowledge of all the drivers and restraints which are derived
through SWOT analysis. North America and Europe Digital Therapeutic (DTx)
Market is a professional and detailed report that highlights primary and
secondary drivers, market share, leading segments and geographical analysis.
North America and Europe digital therapeutic (DTx) market is supportive and aims to reduce the progression of the disease. Data Bridge Market Research analyses that North America and Europe digital therapeutic (DTx) market will grow at a CAGR of 24.8% in North America and 23.53% in Europe during the forecast period of 2023 to 2030.
Download
PDF Sample of North America and Europe Digital Therapeutic (DTx) Market (Including
FULL TOC, Graphs and Tables) of this report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=north-america-and-europe-digital-therapeutics-market
Digital therapeutics (DTx) delivers
evidence-based therapeutics to patients that are operated by high-quality
software programs to forbid, cope, or nurse a medical disorder or disease. They
are utilized individually or in recitals with medicaments, devices, or other
remedies to revamp patient care and health upshot. DTx products subsume
advanced technology best applications relating to design, clinical
affirmations, usability, and data safety. They are corroborated by legislative
bodies as required to hold up product asserts regarding peril, potency, and
deliberated ply. DTx licenses patients, healthcare providers and payers with
attainable tools for inscribing various conditions through high standard
sheltered and virtually data–driven medications.
Opportunities
·
Rising demand for digital therapeutics
The demand for digital therapeutics is
rising as they give the following things: physical and mental goodness,
avoidance, personal care, divided care and shared decision making, long term
condition handling, and correct utilization of urgent and emergency care.
Digital therapeutics provide access to the
optimal level of healthcare services, innovative solutions across all levels,
affordable healthcare solutions for payer, payee and society, quality of
healthcare delivery and solution outcomes can be seen, patient-centricity,
personalization for both patient and staff satisfaction, and also provide
faster diagnosis and action based upon data given and prevention through
education, information, empowerment, alert systems. Thus, the rising demand for
digital therapeutics is expected to act as an opportunity in the market's
growth.
Competitive
Landscape and Home Healthcare Share Analysis
North America and Europe digital
therapeutic (DTx) market competitive landscape provides details by the
competitors. Details included are company overview, company financials, revenue
generated, market potential, investment in research and development, new market
initiatives, global presence, production sites and facilities, production
capacities, company strengths and weaknesses, product launch, product width and
breadth, and application dominance. The above data points provided are only
related to the companies' focus on the inherited North America and Europe
digital therapeutic (DTx) market.
Some
of the major players operating in the North America and Europe digital
therapeutic (DTx) market are: SAMSUNG, Voluntis,
Livongo, Fitbit, Inc., ResMed, Natural Cycles USA Corp, GAIA AG, Smartpatient
gmbh, Kaia Health, Pear Therapeutics Inc. among others.
View
Detailed North America and Europe Digital Therapeutic (DTx) Market@ https://www.databridgemarketresearch.com/reports/north-america-and-europe-digital-therapeutics-market
Recent
Development
·
In January 2023, Pear
Therapeutics, Inc. (Nasdaq: PEAR), the leader in developing and commercializing
software-based medicines called prescription digital therapeutics (PDTs),
announced the inclusion of its PDTs reSET® and reSET-O® on the January 2023 Florida
Medicaid Preferred Drug List (PDL). reSET and reSET-O, the only FDA-authorized
PDTs for the treatment of substance use disorder and opioid use disorder,
respectively, have been added to the Florida Medicaid PDL, effective January 1,
2023
·
In December 2022, Click
Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription
medical treatments, announced that it had received Breakthrough Device
Designation from the U.S. Food and Drug Administration (FDA) for CT-132.
Click’s CT-132 prescription digital therapeutic is under development as an
adjunctive preventive treatment for episodic migraine in patients aged 18 years
and older
Europe
and North America Digital Therapeutic (DTx) Market Segmentation
North America and Europe digital therapeutic
(DTx) market is categorized into four momentous segments, which are based on
product and service type, application, purchase mode and sales channel. The
growth among segments helps you analyze niche pockets of growth and strategies
to approach the market and determine your core application areas and the difference
in your target markets.
Product
and Service Type
·
Hardware Products
·
Solutions/ Software
·
Service
On the basis of product and service type,
North America and Europe digital therapeutic (DTx) market is segmented into
hardware products, solutions/software and service.
By
Application
·
Treatment/Care-Related
Applications
·
Preventive Applications
On the basis of application, North America
and Europe digital therapeutic (DTx) market is segmented into treatment/
care-related applications and preventive applications.
By
Purchase Mode
·
Group Purchase Organization
·
Individual
On the basis of purchase mode, North
America and Europe digital therapeutic (DTx) market is segmented into group
purchase organization and individual.
By
Sales Channel
·
B2B
·
B2C
On the basis of sales channel, North America and Europe digital therapeutic (DTx) market is segmented into B2B and B2C.
Browse
More Reports
https://sites.google.com/view/in-vitrotoxicologytestingmarke/home
https://social.urgclub.com/read-blog/176512
https://talkotive.com/read-blog/93164
https://twoplustwoequal.com/read-blog/12788
https://vherso.com/read-blog/102183
https://waoop.com/read-blog/102893
https://wineart24.com/read-blog/60568
https://markettreports.blogspot.com/2023/08/in-vitro-toxicology-testing-market-size.html
https://www.diigo.com/user/dbmrmarkett/b/720946220
https://www.gamesfree.ca/read-blog/19731
https://www.pickmemo.com/read-blog/213222
https://www.social-vape.com/read-blog/63449
http://zyynor.com/read-blog/79128
https://ai.ceo/read-blog/76453
https://americanwomenorg.com/read-blog/29541
https://app.socie.com.br/read-blog/72280
https://baitk.com/read-blog/50016
https://bicycle.one/read-blog/42410
https://blacksocially.com/read-blog/152365
https://chandrabindu.net/read-blog/9578
https://chatterchat.com/read-blog/58139
https://cynochat.com/read-blog/90021
https://elovebook.com/read-blog/29240
About
Data Bridge Market Research, Private Ltd
Data Bridge Market Research Pvt Ltd is a
multinational management consulting firm with offices in India and Canada. As
an innovative and neoteric market analysis and advisory company with unmatched
durability level and advanced approaches. We are committed to uncover the best
consumer prospects and to foster useful knowledge for your company to succeed
in the market.
Data Bridge Market Research is a result of
sheer wisdom and practice that was conceived and built-in Pune in the year
2015. The company came into existence from the healthcare department with far
fewer employees intending to cover the whole market while providing the best
class analysis. Later, the company widened its departments, as well as expands
their reach by opening a new office in Gurugram location in the year 2018,
where a team of highly qualified personnel joins hands for the growth of the
company. “Even in the tough times of COVID-19 where the Virus slowed down
everything around the world, the dedicated Team of Data Bridge Market Research
worked round the clock to provide quality and support to our client base, which
also tells about the excellence in our sleeve.”
Contact:
Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Comments
Post a Comment